Skip to search formSkip to main contentSkip to account menu

BX 661A

Known as: BX661A 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

balsalazide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic acid disodium salt dihydrate (CAS 80573-04-2, BX661A) is being developed as a… 
1998
1998
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its…
5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic acid disodium salt dihydrate (CAS 80573-04-2, BX661A) is developed as a… 
1998
1998
Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
5-[4-(2-Carboxyethylcarbamoyl)phenylazo]salicylic acid disodium salt dihydrate (CAS 80573-04-2, BX661A) is developed as a… 
1998
1998
潰瘍性大腸炎治療薬5-[4-(2-Carboxyethylcarbamoyle) -phenylazo] Salicylic Acid Disodium Salt Dihydrate (BX661A) の体内動態(第3報) : ラットに単回投与したときの分布および排泄
1997
1997
5-[4-(2-carboxyethylcarbamoyl) phenylazo] salicylic acid disodium salt dihydrate (BX661A) の薬理学的研究. ラットの各種実験的大腸炎モデルに対する効果
1997
1997
潰瘍性大腸炎の治療を目的とした大腸遊離型 5-aminosalicylic acid (5ASA)製剤 "BX661A" の体内動態 (消化管内動態について)
1997
1997
デキストラン硫酸誘発潰瘍性大腸炎モデルラットにおける大腸遊離型 5-aminosalicylic acid 製剤 "BX661A" の体内動態
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)